These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Sulpice L, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Cherqui D, Duvoux C. Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590 [Abstract] [Full Text] [Related]
3. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria. Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN. Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852 [Abstract] [Full Text] [Related]
4. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK. Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152 [Abstract] [Full Text] [Related]
5. Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria. Chua TC, Saxena A, Chu F, Morris DL. Am J Clin Oncol; 2012 Apr; 35(2):141-5. PubMed ID: 21336092 [Abstract] [Full Text] [Related]
6. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT. Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158 [Abstract] [Full Text] [Related]
7. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME, Koneru B, Rocca JP, Wolf DC, Kim-Schluger L, Visintainer P, Klein KM, Chun H, Marvin M, Rozenblit G, Rodriguez-Davalos M, Sheiner PA. Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [Abstract] [Full Text] [Related]
9. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma. Piardi T, Gheza F, Ellero B, Woehl-Jaegle ML, Ntourakis D, Cantu M, Marzano E, Audet M, Wolf P, Pessaux P. Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632 [Abstract] [Full Text] [Related]
10. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA. Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113 [Abstract] [Full Text] [Related]
11. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793 [Abstract] [Full Text] [Related]
12. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB, Ko GY, Park KM, Ha TY, Song GW. Liver Transpl; 2008 Jul; 14(7):935-45. PubMed ID: 18581465 [Abstract] [Full Text] [Related]
13. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria. Fouzas I, Sotiropoulos GC, Lang H, Nadalin S, Beckebaum S, Sgourakis G, Saner FH, Radtke A, Papanikolaou V, Baba HA, Paul A, Broelsch CE, Malagó M. Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228 [Abstract] [Full Text] [Related]
15. A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma. Wang ZX, Song SH, Teng F, Wang GH, Guo WY, Shi XM, Ma J, Wu YM, Ding GS, Fu ZR. Clin Transplant; 2010 Nov; 24(6):752-7. PubMed ID: 20030683 [Abstract] [Full Text] [Related]
17. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Lipshutz G, Yersiz H, Lu DS, Lassman C, Tong MJ, Hiatt JR, Busuttil RW. Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454 [Abstract] [Full Text] [Related]
18. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. D'Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, Thung S, Guido M, del Rio Martin J, Schiano T, Cillo U. Liver Transpl; 2009 Oct; 15(10):1278-87. PubMed ID: 19790142 [Abstract] [Full Text] [Related]
19. Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified? Sotiropoulos GC, Malagó M, Bockhorn M, Schmitz KJ, Radtke A, Molmenti EP, Schaffer R, Beckebaum S, Cicinnati VR, Fouzas I, Broelsch CE, Lang H. Hepatogastroenterology; 2008 Oct; 55(86-87):1671-7. PubMed ID: 19102367 [Abstract] [Full Text] [Related]
20. [Value of liver transplantation in hepatocellular carcinoma treatment]. Zheng SS, Wu J. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):366-70. PubMed ID: 18795603 [Abstract] [Full Text] [Related] Page: [Next] [New Search]